Jimmy Light
Overview
Explore the profile of Jimmy Light including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
337
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Light J, Tucker M
Clin Transplant
. 2013 Mar;
27(3):E256-63.
PMID: 23480129
Introduction: We are reporting the results over a 20 yr period of simultaneous pancreas-kidney transplants in patients with end-stage renal disease and diabetes mellitus. The outcomes of the transplants, performed...
2.
Harbell J, Fung J, Nissen N, Olthoff K, Florman S, Hanto D, et al.
Surgery
. 2012 Sep;
152(3):376-81.
PMID: 22938898
Background: In this report, we examine the surgical safety and complications (SC) among 125 liver (L) and 150 kidney (K) HIV+ transplantation (TX) recipients in a prospective nonrandomized U.S. multicenter...
3.
Melancon J, Cummings L, Graham J, Rosen-Bronson S, Light J, Desai C, et al.
J Am Coll Surg
. 2011 Apr;
212(4):740-5.
PMID: 21463825
Background: Currently ethnic minority patients comprise 60% of patients listed for kidney transplantation in the US; however, they receive only 55% of deceased donor renal transplants and 25% of living...
4.
Orlando G, Stratta R, Light J
Curr Opin Organ Transplant
. 2010 Dec;
16(1):110-5.
PMID: 21150617
Purpose Of Review: This review will provide evidence that selected patients with type 2 diabetes mellitus (T2DM) may benefit from vascularized pancreas transplantation (PTX). Recent Findings: Initial experience with simultaneous...
5.
Stock P, Barin B, Murphy B, Hanto D, Diego J, Light J, et al.
N Engl J Med
. 2010 Nov;
363(21):2004-14.
PMID: 21083386
Background: The outcomes of kidney transplantation and immunosuppression in people infected with human immunodeficiency virus (HIV) are incompletely understood. Methods: We undertook a prospective, nonrandomized trial of kidney transplantation in...
6.
Vincenti F, Mendez R, Curtis J, Light J, Pearson T, Wu Y, et al.
Transplantation
. 2005 Oct;
80(7):910-6.
PMID: 16249738
Background: Monitoring cyclosporine microemulsion (CsA-ME; Neoral) exposure 2 hours postdose (C2) has been reported to optimize the efficacy and safety of CsA-ME therapy. The addition of induction therapy to a...
7.
Jordan S, Tyan D, Stablein D, McIntosh M, Rose S, Vo A, et al.
J Am Soc Nephrol
. 2004 Dec;
15(12):3256-62.
PMID: 15579530
Reported are the reduction of anti-HLA antibody levels and improvement of transplant rates by intravenous immunoglobulin (IVIG) in a randomized, double-blind, placebo-controlled clinical trial. Between 1997 and 2000, a total...
8.
Gonwa T, Johnson C, Ahsan N, Alfrey E, Halloran P, Stegall M, et al.
Transplantation
. 2003 Jun;
75(12):2048-53.
PMID: 12829910
Methods: Two hundred twenty-three recipients of first cadaveric kidney allografts were randomized to receive tacrolimus (TAC) + mycophenolate mofetil (MMF), TAC + azathioprine (AZA), or cyclosporine (Neoral; CsA) + MMF....
9.
Light J, Salomon D, Diethelm A, Alexander J, Hunsicker L, Thistlethwaite R, et al.
Clin Transplant
. 2002 Sep;
16(5):317-24.
PMID: 12225426
Background: The safety and immune tolerance potential of donor marrow infusion with cadaveric source renal transplants was evaluated in a series of non-randomized multicenter pilot trials by the NIH Cooperative...